- CEO
- Joseph N. Forkey
- Full Time Employees
- 76
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 22 East Broadway Gardner MA United States of America 01440
- IPO Date
- Jan 16, 1992
- Business
- Precision Optics Corporation, Inc. (NASDAQ: POCI) designs, develops, manufactures, and sells advanced optical instruments, specialized imaging systems, and related components primarily for the medical, defense, and aerospace industries. Founded in 1982 and headquartered in Gardner, Massachusetts, the company operates as a vertically integrated optics provider with facilities in Gardner, Littleton, Massachusetts, and South Portland, Maine; it serves customers mainly in the United States and the European Economic Area through its proprietary micro-optics, 3D imaging, and digital imaging technologies. Core products and services include medical instrumentation such as rigid laparoscopes, arthroscopes, sinuscopes, specialty endoscopes, micro endoscopes down to 0.6 millimeters in diameter, CMOS endoscopes, 3D endoscopes, endocouplers with focal ranges from 20 to 45 millimeters, parfocal zoom couplers, micro medical cameras, flexible fiber scopes with diameters as small as 5 microns, and custom imaging systems for minimally invasive surgical procedures; micro-optics components encompassing lenses down to 0.37 millimeters, prisms down to 0.10 millimeters, micro assemblies, and optical thin film coatings; as well as industrial and military assemblies including borescopes, illumination systems, and high-resolution optical solutions for jet engine inspection and augmented reality applications. Recent developments include the expansion of production facilities with a new lease in Littleton, Massachusetts, in June 2025 to consolidate engineering and meet a record backlog exceeding $18 million, alongside a new South Portland site for talent access; entry into a $678,000 product development agreement in November 2025 for a next-generation high-definition borescope for jet engines with a major aerospace and defense customer following a competitive supplier evaluation; a main purchase agreement with a top-tier aerospace customer in 2025 expanding program backlog to $6.6 million; record first quarter fiscal 2026 revenue of $6.68 million reflecting 46% year-over-year growth and guidance for full-year revenue over $25 million; a $1.4 million registered direct offering priced in 2024; appointment of Clay Schwabe as Vice President of Sales and Marketing; multiple follow-on production orders from defense customers totaling millions for robotic laparoscopy, cystoscopy, and optical applications; and customer FDA 510(k) clearance accelerating production of single-use endoscope assemblies.